1177 related articles for article (PubMed ID: 18334831)
61. Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma.
Nozoe T; Rikimaru T; Mori E; Okuyama T; Takahashi I
J Surg Oncol; 2006 Aug; 94(2):132-7. PubMed ID: 16847905
[TBL] [Abstract][Full Text] [Related]
62. The predictive value of preoperative carcinoembryonic antigen level in the prognosis of colon cancer.
Kirat HT; Ozturk E; Lavery IC; Kiran RP
Am J Surg; 2012 Oct; 204(4):447-52. PubMed ID: 22481066
[TBL] [Abstract][Full Text] [Related]
63. Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancer.
Zhou YJ; Xie YT; Gu J; Yan L; Guan GX; Liu X
Eur J Surg Oncol; 2011 Dec; 37(12):1078-84. PubMed ID: 21944050
[TBL] [Abstract][Full Text] [Related]
64. Survival of patients with T3 stage III rectal cancer is significantly worse than T2 stage III rectal cancer. A new proposal of a subdivision of stage III rectal cancer.
Hotta T; Takifuji K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Nasu T; Tamura K; Yamaue H
Dig Surg; 2009; 26(1):69-74. PubMed ID: 19169033
[TBL] [Abstract][Full Text] [Related]
65. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
[TBL] [Abstract][Full Text] [Related]
66. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years.
Sadahiro S; Suzuki T; Ishikawa K; Nakamura T; Tanaka Y; Masuda T; Mukoyama S; Yasuda S; Tajima T; Makuuchi H; Murayama C
Hepatogastroenterology; 2003; 50(53):1362-6. PubMed ID: 14571738
[TBL] [Abstract][Full Text] [Related]
67. Long-term prognostic value of conventional peritoneal lavage cytology in patients undergoing curative colorectal cancer resection.
Noura S; Ohue M; Seki Y; Yano M; Ishikawa O; Kameyama M
Dis Colon Rectum; 2009 Jul; 52(7):1312-20. PubMed ID: 19571710
[TBL] [Abstract][Full Text] [Related]
68. Tumor budding and survival after potentially curative resection of node-positive colon cancer.
Sy J; Fung CL; Dent OF; Chapuis PH; Bokey L; Chan C
Dis Colon Rectum; 2010 Mar; 53(3):301-7. PubMed ID: 20173477
[TBL] [Abstract][Full Text] [Related]
69. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
[TBL] [Abstract][Full Text] [Related]
70. Correlates and outcomes of tumor adherence in resected colonic and rectal cancers.
Darakhshan A; Lin BP; Chan C; Chapuis PH; Dent OF; Bokey L
Ann Surg; 2008 Apr; 247(4):650-8. PubMed ID: 18362628
[TBL] [Abstract][Full Text] [Related]
71. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
72. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
[TBL] [Abstract][Full Text] [Related]
73. [Surgical treatment of metastatic lung cancer arising from the colon and rectum].
Sasai T; Shouji T; Tanaka S; Hioki M; Gomibuchi M; Koizumi K; Utsunomiya H; Morioka H; Yamate M
Kyobu Geka; 1989 Jun; 42(6):460-2. PubMed ID: 2779050
[TBL] [Abstract][Full Text] [Related]
74. Colorectal cancer in the young patient.
Minardi AJ; Sittig KM; Zibari GB; McDonald JC
Am Surg; 1998 Sep; 64(9):849-53. PubMed ID: 9731812
[TBL] [Abstract][Full Text] [Related]
75. Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer.
Tweedle EM; Khattak I; Ang CW; Nedjadi T; Jenkins R; Park BK; Kalirai H; Dodson A; Azadeh B; Terlizzo M; Grabsch H; Mueller W; Myint S; Clark P; Wong H; Greenhalf W; Neoptolemos JP; Rooney PS; Costello E
Gut; 2010 Nov; 59(11):1501-10. PubMed ID: 20947885
[TBL] [Abstract][Full Text] [Related]
76. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
77. Prognostic significance of CEA levels and detection of CEA mRNA in draining venous blood in patients with colorectal cancer.
Kanellos I; Zacharakis E; Kanellos D; Pramateftakis MG; Tsahalis T; Altsitsiadis E; Betsis D
J Surg Oncol; 2006 Jul; 94(1):3-8. PubMed ID: 16788936
[TBL] [Abstract][Full Text] [Related]
78. Prognostic value of humbug gene overexpression in stage II colon cancer.
Wang J; de la Monte SM; Sabo E; Kethu S; Tavares R; Branda M; Simao L; Wands JR; Resnick MB
Hum Pathol; 2007 Jan; 38(1):17-25. PubMed ID: 17020779
[TBL] [Abstract][Full Text] [Related]
79. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
80. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
